Affordable Inhalers and Nebulizers Act of 2025
Affordable Inhalers and Nebulizers Act of 2025
Plain Language Summary
# Affordable Inhalers and Nebulizers Act of 2025 - Summary **What the Bill Would Do:** The Affordable Inhalers and Nebulizers Act of 2025 aims to make respiratory medications more affordable and accessible for Americans who need them. While specific provisions aren't detailed in the available information, bills with this title typically focus on reducing out-of-pocket costs for inhalers and nebulizers—devices used to deliver medication for conditions like asthma and COPD—by addressing factors such as insurance coverage, copay limits, or manufacturer pricing practices. **Who It Affects:** This bill would primarily affect Americans with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions who rely on inhalers and nebulizers. It could also impact insurance companies, pharmaceutical manufacturers, and healthcare providers involved in prescribing and distributing these medications. **Current Status:** As of now, the bill (S 2756) is in committee, meaning it hasn't yet been voted on by the full Senate.
It was introduced by Senator Angela Alsobrooks (D-MD). For more detailed information about the bill's specific provisions and any recent developments, you can check Congress.gov or the Senate website.
Latest Action
Read twice and referred to the Committee on Finance.